The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells
David R. Clemmons(University of North Carolina at Chapel Hill), Ling Yan(Hefei University of Technology)
Cited by 1
Related Papers
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
|New England Journal of Medicine|1979|367
Reduction of Plasma Immunoreactive Somatomedin C during Fasting in Humans*
|The Journal of Clinical Endocrinology & Metabolism|1981|366